GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Standard Chemical & Pharmaceutical Co Ltd (TPE:1720) » Definitions » 3-Year EPS without NRI Growth Rate

Standard Chemical & Pharmaceutical Co (TPE:1720) 3-Year EPS without NRI Growth Rate : 30.80% (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Standard Chemical & Pharmaceutical Co 3-Year EPS without NRI Growth Rate?

Standard Chemical & Pharmaceutical Co's EPS without NRI for the three months ended in Mar. 2024 was NT$1.43.

During the past 12 months, Standard Chemical & Pharmaceutical Co's average EPS without NRI Growth Rate was 11.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was 30.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 19.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was 9.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Standard Chemical & Pharmaceutical Co was 30.80% per year. The lowest was -9.50% per year. And the median was 3.35% per year.


Competitive Comparison of Standard Chemical & Pharmaceutical Co's 3-Year EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Standard Chemical & Pharmaceutical Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Standard Chemical & Pharmaceutical Co's 3-Year EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Standard Chemical & Pharmaceutical Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Standard Chemical & Pharmaceutical Co's 3-Year EPS without NRI Growth Rate falls into.



Standard Chemical & Pharmaceutical Co 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Standard Chemical & Pharmaceutical Co  (TPE:1720) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Standard Chemical & Pharmaceutical Co 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Standard Chemical & Pharmaceutical Co's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Standard Chemical & Pharmaceutical Co (TPE:1720) Business Description

Traded in Other Exchanges
N/A
Address
No. 154, Kaiyuan Road, Xinying District, Tainan, TWN, 73055
Standard Chemical & Pharmaceutical Co Ltd is a pharmaceutical company. Along with its subsidiaries, the firm is engaged in the pharmaceutical development, manufacturing, and sales of Active Pharmaceuticals Ingredients (API), health supplements, medical equipment, neoangelac plus milk powder, and adult supplements. It offers pharmaceutical products in healthcare segments including the circulatory system, digestive system, metabolism, anti-microbial, membrane drugs, and respiratory system. The company generates a majority of its revenue from Taiwan.

Standard Chemical & Pharmaceutical Co (TPE:1720) Headlines

No Headlines